Crossmark

Stability considerations for drug-device combination products-21 CFR part 4 update

Crossref DOI link: https://doi.org/10.1186/s41120-023-00078-5

Published Online: 2023-05-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Latoz, Christopher https://orcid.org/0000-0003-2813-4150
Larkin, Laure https://orcid.org/0009-0003-4950-6096
Huynh-Ba, Kim https://orcid.org/0000-0001-7033-643X
License Information

Text and Data Mining valid from 2023-05-01

Version of Record valid from 2023-05-01
More Information

Article History

Received: 4 March 2023

Accepted: 6 April 2023

First Online: 1 May 2023

Declarations

:

: The authors declare that they have no competing interests